8 hrs ago | PR-inside.com
Cook Medical Incorporated - Strategic SWOT Analysis Review - New Market Report
Cook Medical Incorporated is engaged in the development, manufacture, distribution and marketing of devices for the healthcare markets.
New market study, "Endologix, Inc. (ELGX) - Financial and Strategic...
Financial and Strategic SWOT Analysis Review Summary Endologix, Inc. is a medical device company engaged in developing, manufacturing and selling of minimally invasive treatments for aortic diseases.
Endologix's CEO Discusses Q1 2012 Results - Earnings Call Transcript
Greetings and welcome to the Endologix Inc. first quarter 2012 earnings conference call.
Director, Marketing | Endologix, Inc.
About Endologix, Inc. Endologix, Inc. is a developer and manufacturer of minimally invasive treatments for aortic disorders.
Endologix Downgraded by Lazard Capital to "Neutral"
ELGX has been the subject of a number of other recent research reports. Analysts at Oppenheimer raised their price target on shares of Endologix from $14.00 to $17.00 in a research note to investors on Friday, March 16th.